NIH-funded research R01 grant

Identifying protein markers linked to delirium and cognitive decline in older heart surgery patients

Official title: Proteomic Signatures of Delirium and Longterm Cognitive Decline in Older Cardiac Surgical Patients

Funded at Beth Israel Deaconess Medical Center · NIH-11108056 · Data updated 2026-11-12

This study is looking at how certain proteins in the blood might help us understand which older patients are more likely to experience confusion or memory problems after heart surgery, so we can find ways to better support those at risk.

More Cognitive Decline research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startJune 15, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$1,631,690
NIH project number1R01AG092960-01
Project IDNIH-11108056 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults aged 65 and above who are scheduled for cardiac surgery.

Less likely to help

Patients under the age of 65 or those not undergoing cardiac surgery may not benefit from this research.

What this research studies

This research investigates the relationship between specific proteins and the risk of developing delirium and long-term cognitive decline in older patients undergoing cardiac surgery. By analyzing blood samples from patients, the study aims to identify biomarkers that can predict which individuals are at higher risk for these complications. The approach includes utilizing advanced proteomic technology to assess changes in protein levels before and after surgery, allowing for targeted interventions to improve patient outcomes. The findings could lead to better preoperative assessments and tailored treatments for at-risk patients.

Why it matters

Potential benefit: If successful, this research could lead to improved identification and management of older patients at risk for delirium and cognitive decline after cardiac surgery.

How similar studies have gone: Previous research has shown promising results in identifying biomarkers for delirium and cognitive decline, indicating that this approach has potential for success.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Subramaniam, Balachundhar — Beth Israel Deaconess Medical Center
  • Study coordinator: Subramaniam, Balachundhar

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.